Tacrolimus vs Neoral in renal and renal/pancreas transplantation

Clinical Transplantation

Volumn 13, Issue 1 II, 1999, Pages 123-125

  Ghasemian, S Reza ^a   Light, Jimmy A ^a   Currier, Charles ^a   Sasaki, Truman M ^a   Aquino, Alex ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Neoral; Renal transplant; Renal pancreas transplant; Tacrolimus

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

CLINICAL PROTOCOL; CONFERENCE PAPER; CREATININE BLOOD LEVEL; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RECURRENT INFECTION; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 0033031084     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.1999.130110.x     Document Type: Conference Paper

References (11)

1. HOLT DW, MUELLER WA, KOVARIK JM, VAN BREE JB, KUTZ K. The pharmacokinetics of Sandimmune Neoral: a new oral formulation of cyclosporine. Transpl Proc 1994: 26 (5): 2935.
2. VONDERSCHER J, NEINZER A. Rationale for the development of sandimmune Neoral. Transpl Proc 1994: 26 (5): 2925.
3. US MULTICENTER FK506 LIVER STUDY GROUP. A comparison of tacrolimus and cyclosporine for immunosuppression in liver transplantation. N Eng J Med 1994: 331: 1110.
4. SOLEZ K, AXELES RA, BENDIKTSSON H, BURDICK JF, COHEN AH, COLVIN RB et al. The Banff classification of kidney transplant pathology. Kidney Int 1993: 44: 411.
5. GJERTSON WD, CECKA M, TERASAKI PI. The relative effects of FK506 and cyclosporine on short and long term kidney graft survival. Transplantation 1995: 60: 1384.
6. KAHAN B, WELSH M, SCHOENBERG M, RUTZKY LP, KATZ SM, URBAUER DL, VAN BUREN CT. Variable absorption of cyclosporine. Transplantation 1996: 62 (5): 599.
7. BARONE G, BUNKE CM, CHOC MG, JIN JH et al. The safety and tolerability of cyclosporine emulsion versus cyclosporine in randomized, double-blind comparison in primary renal allograft recipients. The Neoral Safety Study Group. Transplantation 1996: 61: 968.
8. PRSCOVITZ MD, BARONE G, CHOC MG, HRICIK DE, HWANG DS et al. Safety and tolerability of cyclosporine microemulsion versus cyclosporine: two year data in primary renal allograft recipients: a report of the Neoral Study Group. Transplantation 1997: 63: 778.
9. WAGNER K, HERGES S, HEEMANN U. Experimental and clinical experience with use of tacrolimus in kidney transplantation. Clin Nephrol 1996: 45: 332.
10. PIRSCH JD, MILLER J, DEIERHOI MH et al. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaver renal transplantation; for the FK506 Kidney Transplant Study Group. Transplantation 1997: 63: 977.
11. KATZNEISON S, CECKA M. Immunosuppressive regimens and their effects on real allograft outcome. Clin Transpl 1996: 28: 361.